1-832-868-1888
order@swbio.com
Catalog Number: |
48373 |
other_names: | Xanthine dehydrogenase antibody Xanthine dehydrogenase/oxidase antibody Xanthine oxidase antibody Xanthine oxidoreductase antibody XD antibody XDH antibody XDH_HUMAN antibody xdha antibody XO antibody xor antibody |
Amount: |
100μg |
calculated_mw: | 146 kDa |
host_species: | Mouse |
Price: |
$529 |
Swiss-Prot No: |
Swiss-Prot#:P47989 |
Form of Antibody: |
1*TBS (pH7.4), 0.5%BSA, 50%Glycerol. Preservative: 0.05% Sodium Azide. |
Storage/Stability: |
|
Immunogen: |
Peptide |
Purification: |
ProG affinity purified |
Specificity/Sensitivity: |
|
Applications: |
IHC,FC |
Background: |
The process of metabolizing purines to a common molecule known as xanthine is an essential process for the proper shuttling of uric acid. Xanthine oxidase is a flavoprotein enzyme that coordinates molybdenum and utilizes NAD+ as an electron acceptor to catalyze the oxidation of hypoxanthine to xanthine and then to uric acid. The predominant form of this enzyme is xanthine dehydrogenase, which is a homodimer that can be converted to xanthine oxidase by sulfhydryl oxidation or proteolytic modification. Xanthine oxidase is present in species ranging from bacteria to human and is ubiquitously expressed in mammalian tissues. In the oxidase form, this enzyme is coupled to the generation of free radicals. Individuals showing marked elevation of serum xanthine oxidase is suggestive of chronic liver disease and cholestasis, which is a condition defined by hepatic obstruction. Hepatic obstruction causes bile salts, the bile pigment bilirubin, and fats to accumulate in the blood stream instead of being eliminated normally. The clinical consequences of defects in xanthine oxidase range from mild to severe and even contribute to fatal disorders. |
References: |
|
appl_detail: |
|
QUICK LINKS
Unique Antibodies Cancer/Apoptosis antibody Tag Antibody Neuroscience antibody MAP kinase antibody Secondary AntibodyCONTACT US
1-832-868-1888 order@swbio.comGET IN TOUCH